150 related articles for article (PubMed ID: 12651869)
1. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.
Ohno K; Sadeh M; Blatt I; Brengman JM; Engel AG
Hum Mol Genet; 2003 Apr; 12(7):739-48. PubMed ID: 12651869
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in the TPR6 domain of the RAPSN gene associated with congenital myasthenic syndrome.
Leshinsky-Silver E; Shapira D; Yosovitz K; Ginsberg M; Lerman-Sagie T; Lev D
J Neurol Sci; 2012 May; 316(1-2):112-5. PubMed ID: 22326364
[TBL] [Abstract][Full Text] [Related]
3. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
[TBL] [Abstract][Full Text] [Related]
4. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
[TBL] [Abstract][Full Text] [Related]
5. A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome.
Abicht A; Stucka R; Schmidt C; Briguet A; Höpfner S; Song IH; Pongratz D; Müller-Felber W; Ruegg MA; Lochmüller H
Brain; 2002 May; 125(Pt 5):1005-13. PubMed ID: 11960891
[TBL] [Abstract][Full Text] [Related]
6. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.
Ohno K; Engel AG; Shen XM; Selcen D; Brengman J; Harper CM; Tsujino A; Milone M
Am J Hum Genet; 2002 Apr; 70(4):875-85. PubMed ID: 11791205
[TBL] [Abstract][Full Text] [Related]
7. Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.
Milone M; Shen XM; Selcen D; Ohno K; Brengman J; Iannaccone ST; Harper CM; Engel AG
Neurology; 2009 Jul; 73(3):228-35. PubMed ID: 19620612
[TBL] [Abstract][Full Text] [Related]
8. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
[TBL] [Abstract][Full Text] [Related]
9. A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome.
Müller JS; Abicht A; Christen HJ; Stucka R; Schara U; Mortier W; Huebner A; Lochmüller H
Neuromuscul Disord; 2004 Nov; 14(11):744-9. PubMed ID: 15482960
[TBL] [Abstract][Full Text] [Related]
10. Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil.
Estephan EP; Zambon AA; Marchiori PE; da Silva AMS; Caldas VM; Moreno CAM; Reed UC; Horvath R; Töpf A; Lochmüller H; Zanoteli E
Neuromuscul Disord; 2018 Nov; 28(11):961-964. PubMed ID: 30266223
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
[TBL] [Abstract][Full Text] [Related]
12. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
Banwell BL; Ohno K; Sieb JP; Engel AG
Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of muscle plasticity: differential regulation of troponin I genes by electrical activity.
Calvo S; Stauffer J; Nakayama M; Buonanno A
Dev Genet; 1996; 19(2):169-81. PubMed ID: 8900050
[TBL] [Abstract][Full Text] [Related]
14. Analysis of binding and activating functions of the chick muscle acetylcholine receptor gamma-subunit upstream sequence.
Jia HT; Tsay HJ; Schmidt J
Cell Mol Neurobiol; 1992 Jun; 12(3):241-58. PubMed ID: 1330309
[TBL] [Abstract][Full Text] [Related]
15. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.
Maselli RA; Dunne V; Pascual-Pascual SI; Bowe C; Agius M; Frank R; Wollmann RL
Muscle Nerve; 2003 Sep; 28(3):293-301. PubMed ID: 12929188
[TBL] [Abstract][Full Text] [Related]
16. Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.
Brugnoni R; Maggi L; Canioni E; Moroni I; Pantaleoni C; D'Arrigo S; Riva D; Cornelio F; Bernasconi P; Mantegazza R
J Neurol; 2010 Jul; 257(7):1119-23. PubMed ID: 20157724
[TBL] [Abstract][Full Text] [Related]
17. Identification of pathogenic mutations in the human rapsyn gene.
Dunne V; Maselli RA
J Hum Genet; 2003; 48(4):204-7. PubMed ID: 12730725
[TBL] [Abstract][Full Text] [Related]
18. Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.
Cossins J; Burke G; Maxwell S; Spearman H; Man S; Kuks J; Vincent A; Palace J; Fuhrer C; Beeson D
Brain; 2006 Oct; 129(Pt 10):2773-83. PubMed ID: 16945936
[TBL] [Abstract][Full Text] [Related]
19. Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.
Gaudon K; Pénisson-Besnier I; Chabrol B; Bouhour F; Demay L; Ben Ammar A; Bauché S; Vial C; Nicolas G; Eymard B; Hantaï D; Richard P
J Med Genet; 2010 Dec; 47(12):795-6. PubMed ID: 20930056
[TBL] [Abstract][Full Text] [Related]
20. Distinct phenotypes of congenital acetylcholine receptor deficiency.
Burke G; Cossins J; Maxwell S; Robb S; Nicolle M; Vincent A; Newsom-Davis J; Palace J; Beeson D
Neuromuscul Disord; 2004 Jun; 14(6):356-64. PubMed ID: 15145336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
